- Home
- XAIR vs AKTX Comparison
XAIR vs AKTX Comparison
Compare XAIR & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- AKTX
- Stock Information
- Founded
- XAIR 2011
- AKTX N/A
- Country
- XAIR United States
- AKTX United States
- Employees
- XAIR N/A
- AKTX N/A
- Industry
- XAIR Medical/Dental Instruments
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- XAIR Health Care
- AKTX Health Care
- Exchange
- XAIR Nasdaq
- AKTX Nasdaq
- Market Cap
- XAIR 33.6M
- AKTX 29.5M
- IPO Year
- XAIR N/A
- AKTX N/A
- Fundamental
- Price
- XAIR $0.46
- AKTX $0.99
- Analyst Decision
- XAIR Strong Buy
- AKTX
- Analyst Count
- XAIR 4
- AKTX 0
- Target Price
- XAIR $3.67
- AKTX N/A
- AVG Volume (30 Days)
- XAIR 731.9K
- AKTX 80.4K
- Earning Date
- XAIR 02-10-2025
- AKTX 02-15-2025
- Dividend Yield
- XAIR N/A
- AKTX N/A
- EPS Growth
- XAIR N/A
- AKTX N/A
- EPS
- XAIR N/A
- AKTX N/A
- Revenue
- XAIR $2,342,000.00
- AKTX N/A
- Revenue This Year
- XAIR $230.80
- AKTX N/A
- Revenue Next Year
- XAIR $265.55
- AKTX N/A
- P/E Ratio
- XAIR N/A
- AKTX N/A
- Revenue Growth
- XAIR 685.91
- AKTX N/A
- 52 Week Low
- XAIR $0.30
- AKTX $0.90
- 52 Week High
- XAIR $2.36
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- XAIR 47.58
- AKTX 31.38
- Support Level
- XAIR $0.44
- AKTX $0.95
- Resistance Level
- XAIR $0.50
- AKTX $1.13
- Average True Range (ATR)
- XAIR 0.04
- AKTX 0.15
- MACD
- XAIR -0.01
- AKTX 0.02
- Stochastic Oscillator
- XAIR 25.36
- AKTX 15.15
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).